Lv41
760 积分 2023-08-02 加入
Use of tissue cross-reactivity studies in the development of antibody-based biopharmaceuticals: history, experience, methodology, and future directions
1个月前
已完结
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
1个月前
已完结
Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development
1个月前
已完结
Population pharmacokinetics of therapeutic monoclonal antibodies
1个月前
已完结
Preclinical safety evaluation of biotechnology-derived pharmaceuticals
1个月前
已完结
Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
1个月前
已完结
Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis
1个月前
已完结
FcRn: the neonatal Fc receptor comes of age
1个月前
已完结
The safety and side effects of monoclonal antibodies
1个月前
已完结
Elimination mechanisms of therapeutic monoclonal antibodies
1个月前
已完结
皖公网安备34019202002308
